The worse the eczema, the lower the vitamin D

Atopic dermatitis is a common and often frustrating skin condition, and sufferers are routinely offered a long list of unproven add-ons alongside their prescribed care. Vitamin D is one of the more plausible candidates: earlier studies hinted that blood levels of 25-hydroxyvitamin D might be associated with the condition, and that supplementation might reduce its severity. Because vitamin D status varies with sunlight, latitude and season, the question needs careful pooling across regions rather than reliance on single studies. This review set out to test both the association and the effect of supplementing.

The authors systematically reviewed all published studies in the MEDLINE, Embase and Cochrane Library databases that examined serum 25-hydroxyvitamin D levels or vitamin D supplementation in relation to atopic dermatitis. Twenty studies covering 1882 cases of the condition were included in the meta-analysis. Analyses compared vitamin D levels between patients and healthy controls, and between severity grades of the condition. The authors also provided stratified analyses based on latitude and region, since sunlight exposure plausibly shapes both vitamin D levels and study results.

People with atopic dermatitis had significantly lower 25-hydroxyvitamin D levels than healthy controls. Within patients, those with severe disease had significantly lower levels than those with mild or moderate disease, suggesting the relationship tracks severity rather than merely the presence of the condition. Vitamin D supplementation was associated with improved symptoms. The authors flag, however, that seasonal and environmental changes, sunlight exposure and cultural practices could confound the link, and that randomised controlled trials assessing it remain limited.

The review consolidates a pattern scattered across earlier individual studies into a consistent picture: lower vitamin D accompanies worse atopic dermatitis, and supplementation shows promise. What it cannot do is settle the direction of cause. People with severe eczema might, for instance, spend less time in the sun rather than low vitamin D driving their severity. The authors explicitly call for further research to confirm the presence and direction of causality, and the shortage of randomised trials is the main gap keeping this at promising rather than proven.

If you manage eczema, this is a reason to see vitamin D status as genuinely relevant to your condition, particularly if your symptoms are severe. It is not yet proof that supplementing will calm your skin, since the trials testing that directly are limited and confounders like sun exposure muddy the picture. Worth knowing and worth raising with whoever looks after your skin, rather than treating it as a settled fix.